Industry Update: Eli Lilly to Acquire Orna Therapeutics to Advance Cell Therapies
Industry Update: Providence Therapeutics Commences mRNA PCV Trial in Australia for Brain Cancers
Industry Update: CREATE Medicines Demonstrates B-Cell Depletion & Repeatable Dosing with In Vivo CAR-T
Industry Update: NeuCyte & Grann Pharma Enter Partnership for mRNA-Based Therapies for Rare Neurological Diseases
Industry Update: Adjuva Bio Awarded CELLSCRIPT™ 2026 mRNA Research Grant to Enhance Next-Gen In Vivo Cell Therapies

Taking Phase 1 Clinical Process to Commercial: Design, Characterization & Validation of mRNA Manufacturing Process for Commercial Production

By | 16 February 2026

Phase appropriate process development for mRNA manufacturing
Aligning with regulatory expectations for commercial mRNA processes for ex vivo and in vivo cell and gene therapy (CGT) applications
Characterization and validation of processes for commercial mRNA production